Welcome to the HBV Advocate’s AASLD Conference coverage. In an effort to best serve our readership, we will post all the important and interesting abstracts about HBV from the conference. While attending the conference, we will update any abstracts that we personally cover at the conference. The updated abstracts will be marked with the date that they have been updated and posted. The other abstracts posted to the web site are HBV related abstracts posted to www.aasld.org that we have not been able to report on or update.

To locate specific abstracts for each topic below, click on the links.

Please click here to view our fact sheet on reading and understanding an abstract.

Thank You,

Alan Franciscus

Editor-in-Chief

Hepatitis B

• Adefovir (Hepsera)
  
  
• Alternative Treatment
  
  
• Assessing When Treatment Will Work
  
  
• Depression and Interferon Treatment
  
  
• Development of Antiviral Resistance
  
  
• Entecavir (Baraclude)
  
  
• HCV-HBV Coinfection
  
  
• Impact of HBV Strains or Genotypes
  
  
• Interferon and Antiviral Combinations
  
  
• Mother-to-Newborn (Perinatal) Infection
  
  
• Pegylated Interferon (Pegasys)
  
  
• Quality of Care Faulted
  
  
• Telbivudine (Tyzeka)
  
  
• Tenofovir (Viread)
  
  
• Treatment in Patients with Severe or Decompensated Liver Disease
  
  
• When can antiviral treatment be stopped?